Who needs to be allocated in icu after thoracic surgery? An observational study by Pinheiro, Liana et al.
Research Article
Who Needs to Be Allocated in ICU after Thoracic Surgery?
An Observational Study
Liana Pinheiro, Ilka Lopes Santoro, and Sonia Maria Faresin
Respiratory Division, Universidade Federal de Sa˜o Paulo (UNIFESP), 04023-062 Sa˜o Paulo, SP, Brazil
Correspondence should be addressed to Ilka Lopes Santoro; ilkasantoro@gmail.com
Received 24 February 2016; Accepted 23 June 2016
Academic Editor: Alberto Ruano-Ravina
Copyright © 2016 Liana Pinheiro et al.This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Background. The effective use of ICU care after lung resections has not been completely studied. The aims of this study were to
identify predictive factors for effective use of ICU admission after lung resection and to develop a risk composite measure to
predict its effective use.Methods. 120 adult patients undergoing elective lung resectionwere enrolled in an observational prospective
cohort study. Preoperative evaluation and intraoperative assessment were recorded. In the postoperative period, patients were
stratified into two groups according to the effective and ineffective use of ICU. The use of ICU care was considered effective if a
patient experienced one or more of the following: maintenance of controlled ventilation or reintubation; acute respiratory failure;
hemodynamic instability or shock; and presence of intraoperative or postanesthesia complications. Results. Thirty patients met the
criteria for effective use of ICU care. Logistic regression analysis identified three independent predictors of effective use of ICU
care: surgery for bronchiectasis, pneumonectomy, and age ≥ 57 years. In the absence of any predictors the risk of effective need
of ICU care was 6%. Risk increased to 25–30%, 66–71%, and 93% with the presence of one, two, or three predictors, respectively.
Conclusion. ICU care is not routinely necessary for all patients undergoing lung resection.
1. Introduction
The current limitations on financial resources available for
healthcare pose a serious challenge worldwide, but partic-
ularly in developing countries. At the same time the intro-
duction of advanced health technologies has led to greater
family/patient expectations with regard to treatment options
and outcomes. These two factors have led to an increased
demand for high tech treatment options, including the use
of intensive care unit (ICU) services, which add substantial
cost to patients’ hospitalization.
In Brazil, ICU admission is routine following lung
resection. In Brazil and other developing countries, lung
resection is done not only for lung cancer, which constitutes
the principal indication for this surgical procedure, but
also for bronchiectasis or sequel of pulmonary tuberculosis.
Many candidates for lung resection are elderly and have
comorbidities that could increase the occurrence of life-
threatening events, which might contribute to increased
demand for ICU care. However, many of these patients are
hemodynamically stable and can be extubated immediately
after the surgical procedure. Regardless, they are routinely
referred to the ICU for surveillance. This indiscriminate
use of ICU services following lung resection contradicts the
European Respiratory Society/European Society of Thoracic
Surgeons guideline recommendation that admission to the
ICU after thoracotomy should not be done on a regular basis.
Moreover, it might lead to clinical problems such as increased
risk of nosocomial infection or delirium and to ICU bed
shortage and increase in hospital expenditure [1–3].
Few studies have investigated characteristics of patients
undergoing lung resection to identify factors associated with
effective use of ICU care in the postoperative period [4–6].
The aims of this study are to identify predictive factors for
effective use of ICU admission after lung resection and to
develop a risk composite measure to predict effective use.
2. Methods
2.1. Study Design. We performed an observational prospec-
tive cohort study from July 2009 to April 2012. 120 patients
over 18 years of age, complete preoperative evaluation, who
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were undergoing elective lung resection for diagnosed or
suspected benign/malignant lung disease who underwent
lung resection, were enrolled consecutively. Exclusion criteria
were as follows: another surgical procedure in addition to
lung resection, no resection of lung parenchyma, and death
during intraoperative period.
All patients signed the informed consent for the study
before preoperative procedures. This study was approved by
the local Ethics Committee of the Universidade Federal de
Sa˜o Paulo (CEP 0410/09; Chairperson: Professor Dr. Jose´
Osmar Medina Pestana) on 30 April 2009.
2.2. Baseline Assessments. Preoperative evaluation was col-
lected using a structured data collection format. The fol-
lowing data were recorded: complete clinical history, phys-
ical examination, age, gender, smoking history, significant
comorbidities, routine blood tests, electrocardiography, pulse
oximetry, American Society of Anesthesiologists (ASA)
score [7–9], pre- and postbronchodilator spirometry, car-
diopulmonary exercise tests (CPET), pulmonary perfusion
scan, fiber optic bronchoscopy, and thoracic computed
tomography scans. Thirty-one study subjects were evalu-
ated for carbon monoxide lung diffusion capacity measure-
ment (DLCO). The preoperative physiologic evaluation was
performed according to the American College of Chest
Physicians (ACCP) Guideline [10] adapted to our institu-
tion scenario. Operability criteria were predicted by pre-
dicted postoperative forced expiratory volume in one second
(ppoFEV
1
) ≥40%, predicted postoperative carbon monoxide
lung diffusion capacity (ppoDLCO) ≥40%, and maximum
oxygen consumption (VO
2
max) at cycloergospirometry ≥
10mL/Kg/min.
2.3. Intraoperative Assessments. All operations were carried
out by the same team of chest surgeons and at the same
tertiary referral hospital.The surgical team included certified
thoracic surgeons and residents.
After anesthesia induction, a double-lumen tube was
inserted. Thoracic epidural anesthesia was initiated intra-
operative and continued postoperatively until chest-drain
removal or at least 72 hours. Moreover, the protective anes-
thetic regimen with low tidal volume was not performed in
regular basis. The number of patients that were extubated
in the operating room was also recorded. Excessive fluid
administration during lung resections was avoided in order
to minimize pulmonary injury [11].
All patients had lung resections (minor or major) via
open thoracotomy (no VATS).
The intraoperative variables recorded were anesthesia
time, operative procedure, and surgical and medical compli-
cations.
2.4. Postoperative Assessments. After surgery, pain control
was achieved by intravenous or epidural analgesia. All
patients were transferred to the ICU, which was staffed by
critical care intensivist physicians who are pulmonologists.
The nurse-to-patient ratio was 0.5 and dedicated paramedical
personnel (nursing staff and chest physiotherapists) were
available.
Postoperative evaluation was also collected using a struc-
tured data collection format. Cardiopulmonary and surgical
complications, as well as mortality, were recorded. Patients
were transferred to the thoracic surgery ward when they were
in stable cardiopulmonary condition.
In the postoperative period, the patients were stratified
into two groups according to the use of ICU admission:
effective use of ICU group and ineffective use of ICU group.
Effective use of ICU was defined as the presence of
one or more of the following characteristics postoperatively:
maintenance of controlled ventilation after surgery or rein-
tubation; acute respiratory failure; hemodynamic instability,
shock or intraoperative/postanesthesia complications includ-
ing hemodynamic instability, cardiac arrhythmia, blood
hypertension, and bronchospasm.
2.5. Statistical Methods. Categorical variables were summa-
rized as absolute and relative frequencies (percentage). Chi-
squared test or the Fisher exact test was used to compare
categorical variables as appropriate. Continuous data were
presented as mean and standard deviation (SD), median
and interquartile range [IQR]. Student’s 𝑡-test or the Mann-
Whitney test was used to compare continuous variables as
appropriate.
After the univariate regression analysis, the variables with
greater odds ratio, without interactions, were included in
a multiple logistic regression analysis, conducted using the
stepwise model to identify independent predictive factors for
effective use of ICU admission.The evaluation of the adjusted
model was based on −2-log likelihood and Nagelkerke 𝑅2.
Age ≥ 57 years (variable median), surgery for bronchiectasis,
pneumonectomy, and ASA score were the variables included
in the final model. Next, the predictive model coefficient and
the possible risk factor combinations were computed. These
predictions were then compared with the observed adverse
outcome rates by using various discrepancy measurements.
Results were considered significant if the 𝑝 value was less
than 0.05. Analysis was performed by the Statistical Package
for the Social Sciences for Windows (SPSS) version 19.0.
3. Results
The general characteristics of the 120 patients included in
this study are summarized in Table 1. The average age was
56.2 years old. The majority were male (54.2%) and current
or ex-smoker (62.5%). The means of spirometric parameters
were within the normal range.The great majority received an
ASA classification of 2 (92.3%) and 65.8% had a diagnosis of
malignant disease.
The mean duration of anesthesia was 6.1 ± 1.8 hours.
Sixteen pneumonectomies (13.4%), one bilobectomy (0.8%),
58 (48.3%) lobectomies, 16 (13.4%) segmentectomies, two
resections of three segments, and 27 (22.5%) other minor
procedures were carried out. The greater part of patients (111
patients – 92.5%) was extubated in the operating room.
A total of 39 patients (32.5%) had 89 complications.
Eighteen patients (15%) experienced clinical complications,
nine (7.5%) surgical, and 12 (10%) both. Five patients (4.2%)
developed bronchopleural fistula, 15 patients (12.5%) had
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Table 1: Characteristics of patients included in the study.
Variables Value
Patient, n 120
Male, n (%) 65 (54.2)
Age and years, mean (SD) 56.2 (12.3)
Respiratory symptoms, median [IQR] 2 [0–3]
Comorbities, median [IQR] 2 [1–3]
Charlson index, median [IQR] 3 [2–4]
Current or ex-smoker, n (%) 75 (62.5)
ASA physical status, n (%)
1 4 (3.3)
2 111 (92.5)
3 5 (4.2)
Functional parameters, % predict (n), mean (SD)
FVC (120) 88.4 (17.6)
FEV
1
(120) 82.3 (19.2)
FEV
1
/FVC (120) 0.75 (0.1)
ppoFEV
1
(120) 72.4 (19.3)
DLCO (31) 64.4 (19.0)
ppoDLCO (31) 53.4 (15.2)
Diagnosis after surgery, n (%)
Benign 41 (34.2)
Malignant 79 (65.8)
Primary lung cancer 52 (65.8)
Metastatic lung cancer 27 (34.2)
IQR: interquartile ratio; DLCO: carbon monoxide lung diffusion capacity;
FEV1: forced expiratory volume in one second; FVC: forced volume capacity;
n: number of patients; ppoDLCO: predicted postoperative carbon monoxide
lung diffusion capacity; ppoFEV1: predicted postoperative forced expiratory
volume in one second; SD: standard deviation.
pneumonia, seven patients (5.8%) had arrhythmia, and none
patient experienced myocardial infarct.
The 30-day mortality rate was 2.5% or three patients. The
cause of death was septic shock, a result of pulmonary infec-
tion in one patient and bronchopleural fistula in two patients.
These patients had been diagnosed with bronchiectasis and
Aspergillus coinfection. Two also had COPD.
The characteristics of patients included in the effective
use and ineffective use of ICU groups are shown in Table 2.
A significantly higher proportion of patients in the effective
use group had respiratory symptoms (93%), comorbidities,
ASA classification of 3 (17%), pneumonectomies (27%), and
benign diseases (50%) compared to the ineffective use group.
Mean anesthesia timewas significantly longer for the effective
use group compared to ineffective use group (6.9 h versus
5.9 h); no difference was found between the groups in terms
of gender, age, smoking history, or spirometry values.
On the first postoperative day, 12 patients (40%) from the
effective use of ICU group were clinically stable and were
transferred to the thoracic surgery ward. All patients in the
ineffective use group were transferred to the thoracic surgery
ward on the first postoperative day.
The morbidity rate in the effective use of ICU group was
100% and the mortality was 6.6%, while in the ineffective
Table 2: Comparison of effective use of ICU group ineffective use
of ICU group characteristics.
Effective use of
ICU 𝑝
Yes
n = 30
No
n = 90
Male, n (%) 17 (57%) 48 (53%) 0.75
Age and years, mean (SD) 58 (13) 55 (12) 0.23
Smokers and ex-smokers, n (%) 19 (63%) 56 (62%) 0.91
Respiratory symptoms, n (%) 28 (93%) 60 (67%) 0.004
Comorbidities, median [IQR] 2 [2-3] 2 [1–3] 0.04
Charlson index, median [IQR] 3 [2–4] 3 [2–4] 0.26
ASA
1 0 (0%) 4 (5%)
<0.0012 25 (83%) 86 (95%)
3 5 (17%) 0 (0%)
Functional tests, % predict, mean SD
FVC 85 ± 19 89 ± 17 0.22
FEV
1
/FVC 0.73 ±
0.14
0.75 ±
0.10
0.38
ppoFEV
1 66 ± 17 74 ± 20 0.06
DLCO
60 ± 20
(n = 31)
67 ± 18
(n = 31) 0.38
ppoDLCO
51 ± 16
(n = 31)
55 ± 15
(n = 31) 0.51
Anaesthesia time, hours, mean (SD) 6.9 (1.9) 5.9 (1.7) 0.008
n resected segments, median [IQR] 3 [1.75–9] 3 [0–5] 0.18
Pneumonectomy, 𝑛 (%) 8 (27%) 8 (9%) 0.03
Histopathological diagnosis
Benign 15 (50%) 26 (29%)
0.025Malign 13 (43%) 39 (43%)
Metastasis 2 (7%) 25 (28%)
ASA: American Society of Anaesthesiologists;DLCO: carbonmonoxide lung
diffusion capacity; FEV1 = forced expiratory volume in one second; FVC:
forced volume capacity; IQR: interquartile ratio; n: number; ppoDLCO:
predicted postoperative carbonmonoxide lung diffusion capacity; ppoFEV1:
predicted postoperative forced expiratory volume in one second; SD: stan-
dard deviation.
use group the morbidity and mortality were 10% and 1.1%,
respectively.
Logistic regression analysis showed that, after adjusting
for ASA score of 3 (reference < 3), the surgical treatment of
bronchiectasis, pneumonectomy, and age ≥ 57 years old were
independent predictors for the effective use of ICU admission
in the postoperative period of lung resection (odds ratio 6.7,
5.8, and 5.2, resp.) (Table 3).
The regression coefficients were used in an equation to
predict the risk of effective use of ICU in the postoperative
period of pulmonary resection considering the presence or
absence of three risk factors: surgical treatment of bronchiec-
tasis, pneumonectomy, and age≥ 57 years. From this equation
we obtained eight risk groups of effective use of ICU which
could be clustered into four groups: no predictor, 6% risk; one
risk predictor, 25 to 30% risk; two predictors, 66 to 71% risk;
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Table 3: Multivariate analysis of the three most important risk
factors of effective use of ICU care after lung resection.
Variable Coefficient SE 𝑝 OR 95% CI
Bronchiectasis 1.905 0.619 0.002 6.72 1.99–22.63
Pneumonectomy 1.757 0.753 0.020 5.79 1.32–25.37
Age ≥ 57 years 1.644 0.604 0.007 5.18 1.58–16.91
Constant −2.745 0.571 <0.001
CI: confidence interval; OR: odds ratio; SE: standard error.
Table 4: Risk of effective use of ICU after lung resection considering
the presence or absence of identified risk factors.
Groups Bronchiectasis Pneumonectomy Age ≥ 57years
% risk
ICU
admission
1 No No No 6
2 No No Yes 25
3 No Yes No 27
4 Yes No No 30
5 No Yes Yes 66
6 Yes No Yes 69
7 Yes Yes No 71
8 Yes Yes Yes 93
three predictors, 93% risk (Table 4). Taking as reference the
first group (no predictor), the risk for effective use of ICU in
the postoperative period of lung resection in the presence of
one, two or three predictors increased the risk of effective use
of ICU by 5, 10, and 15 times, respectively.
4. Discussion
This observational prospective cohort study evaluated the
effective use of admission to the ICU after lung resection
among patients in Sao Paulo, Brazil. Patients in the effective
use of ICU group were clinically worse than those in the
ineffective use group. More patients in the effective use group
had comorbidities and respiratory symptoms. A higher pro-
portion of patients in the effective use group were classified
as ASA 3. In addition there were more pneumonectomies,
longer anesthesia time, and greater number of benign dis-
eases, particularly bronchiectasis, in the effective use group.
Logistic regression analysis confirmed that surgical treat-
ment of bronchiectasis, pneumonectomy, and age ≥ 57 years
was independent predictors for the effective use of ICU. The
final model established eight incremental risk groups, which
could be reduced to four risk groups. The risk of effective use
of ICU after lung resection was roughly equal to the baseline
risk (6%) times the number of independent predictors (one,
two, or three) multiplied by 5.
Two important aspects should be taken into account in
terms of minimizing the ICU admission; firstly the literature
has shown some evidence concerning pulmonary rehabili-
tation in the preoperative scenario for patients undergoing
lung resection surgery [12]. In our study, the preoperative
rehabilitation was not feasible due to the short time interval
between referral and surgery or logistic reasons. Secondly, it
is essential to highlight that the protective anesthetic regimen
(low tidal volume and low driving insufflation pressure) was
applied specially during pneumonectomy procedure.
In our study all patients were referred to the ICU
because there is no intermediate care unit at our institution
able to provide adequate monitoring and intensive nursing
care. Among the 30 patients who required ICU by our
defined criteria, 12 (40%) were clinically compensated and
were transferred to the thoracic surgery ward on the first
postoperative day. These patients might have been admitted
to an intermediate care unit had one been available.
Only three previous studies have investigated predictors
of ICU use in the postoperative period of lung resection [4–
6]. None were done in developing countries. Two of three
studies included only patients with lung cancer and major
resections. The present study included major and minor
resections in patients with malignant and benign diseases.
This decision was based on the fact that, in developing
countries such as Brazil, thoracic surgery for bronchiectasis
and for posttuberculosis pulmonary sequel is commonplace.
Despite the fact that benign lung diseases like bronchiec-
tasis generally affect younger patients, the surgical morbidity
and mortality rates are higher for benign disease than for
malignant disease. Studies over the last decade showed mor-
bidity rates from 18 to 53% and mortality from zero to 26.3%
for benign disease [13–17]. In the present study, themorbidity
and mortality rates among patients with bronchiectasis were
56% and 12%, respectively, confirming our preliminary clin-
ical observation and justifying the inclusion of this group of
patients in our sample.
Although the characteristics of the study population in
the present study were different from those of the previous
studies on effective use of ICU care following lung resection,
some of the conclusions from this study are similar to
those of the previous studies. In 2006, Pieretti et al. [4]
published a retrospective study to evaluate factors predicting
the use for intensive care in patients undergoing major
lung resection. Twenty eight per cent of the study subjects
effectively required intensive care. Similar to the present
study, this group of patients was older and had higher rates
of comorbidities, higher ASA scores, and higher number of
pneumonectomies. This group had also lower PaO
2
, FEV
1
,
ppoFEV
1
, DLCO, ppoDLCO, and PPP (product of % ppoFEV1
and ppoDLCO). Stepwise regression generated two models.
The first identified PPP and ASA score as independent
predictors of effective use of ICU care; the second identified
ppoDLCO and ASA score as independent predictors.
Brunelli et al. [5], in 2008, developed and validated the
first scoring system to predict ICU admission for compli-
cations after major lung resections. Emergency admission
to the ICU was considered when the patient developed
major cardiopulmonary complications requiring advanced
life-support treatments. Among the 1297 patients included in
that study 6.3% had ICU admission for complications and
1.6% died. Pneumonectomy, age > 65 years, ppoFEV
1
below
65%, ppoDLCO below 50%, and cardiac comorbidity were
identified as independent predictors of ICU use. The ICU
scoring system was developed by proportional weighting of
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the logistic regression coefficients and was validated by the
authors, as well as by a second group, Okiror et al. [6], who
found the scoring system to have a moderate discriminating
ability to predict the risk for ICU admission after lung
resection.
In our study, a higher number of pneumonectomies were
observed in the effective use of ICU group and pneumonec-
tomy was identified as an independent predictor of effective
ICU use. Brunelli et al. [5] also identified pneumonectomy as
an independent predictor. In that study, when pneumonec-
tomy was the only risk factor, the risk of requiring ICU
care ranged from 10 to 20%, while in the present study the
risk was 27%. This relatively low risk suggests that patients
with only pneumonectomy as a risk factor may be candidates
for an intermediate care unit, rather than an ICU. This
could save substantial costs as many studies have shown that
hospital costs rises geometrically when ICU is the local of the
treatment [18].
Brunelli et al. [5] found also that age over 65 years was a
predictive factor of use for ICU after lung resection. Age was
also found to be predictive in the present study, but the value,
≥ 57 years, was lower.
ASA classification was identified as a predictive factor
for ICU use following lung resection in the present study
and in the study by Pieretti et al. [4] ASA classification is
a widespread tool that is easy to use [8, 19]. Although it is
a good predictor of morbidity and mortality [20] it is vital
to reinforce that the ASA score was not designed to identify
individual anesthetic or surgical risk [9]. Moreover, the ASA
scale may lack scientific precision, since some studies have
demonstrated a lack of reliability among anesthesiologists
in assigning ASA scores [7, 8]. Another important point
of controversy is inconsistent application of the term “sys-
temic disease.” Bronchiectasis with repeated or significant
hemoptysis is not considered “systemic diseases” in the
ASA classification and therefore is not considered in the
classification [19]. In our study, that disease strongly affected
the risk of effective use of ICU admission.
The three previous studies identifiedDLCO as an indepen-
dent predictive factor for ICU use following lung resection.
We were not able to fully evaluate DLCO as a potential
predictor because of limited test availability at our institution.
The DLCO was only performed on 31 selected patients in
our study group, according to the American College of
Chest Physicians (ACCP) Guideline [10] adapted to our
institutional scenario.
The main limitation of our study is the sample size which
was restricted by the fact that patients were recruited from a
single centre. However, there were several advantages to the
single centre design: operative procedures were performed by
the same surgical team, preoperative clinical evaluation was
performed by the same clinical team, and the postoperative
and ICU care was homogenous.
In conclusion, although all of the patients in this study
were admitted to the ICU following lung resection, only
25% exhibited effective use for ICU care. Three indepen-
dent predictors were identified for effective use: surgery
for bronchiectasis, pneumonectomy, and age ≥ 57 years.
Without any of these predictors, the risk of requiring ICU
care was 6%. The presence of one, two, or three predictors
increased the risk of effective use of ICU care by 5, 10, and 15
times, respectively. These results suggest that ICU care is not
routinely necessary for all patients undergoing lung resection.
Even patients with one risk factor may not require ICU care
if an intermediate care unit is available. Hospitals should
consider the costs and benefits of establishing intermediate
care units.
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